News
Serena Williams Lost 31 Pounds on GLP-1 Drug Zepbound: What to Know
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis legend shared the weight loss medication along with regular exercise and a healthy diet helped her lose 31 pounds.
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
Baller Alert on MSN8d
Ozempic and Zepbound Lawsuits Explode: Patients Say Popular Weight-Loss Drugs Left Them Hospitalized
More than 2,000 lawsuits are now targeting the makers of Ozempic and Zepbound, with patients claiming the drugs caused dangerous and sometimes permanent health problems. The cases, consolidated in ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For ...
GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were ...
16h
Eli Lilly could bring first widely available GLP‑1 pill for obesity, diabetes to market this year
Eli Lilly says its weight loss pill orforglipron could win approval this year after a trial showed over 10% weight loss in ...
A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.
Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading ...
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback